Investor Class Action Strikes At CardioNet's Heart

Law360, New York (September 16, 2009, 4:57 PM EDT) -- Investors in medical device manufacturer CardioNet Inc. have sued the company and two of its executives for allegedly issuing false and misleading statements to artificially inflate CardioNet's stock price earlier this year.

In a putative class action filed Sept. 15 in the U.S. District Court for the Eastern District of Pennsylvania, investors accuse CardioNet and its CEO and chief financial officer of making aggressive projections for the company's mobile cardiac outpatient telemetry device and downplaying the potential for reduced reimbursement rates.

The suit quotes CardioNet CEO...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.